NEWS

CGRP antibodies are coming to Canada and are stirring a lot of interest from the medical community.  Patients also have many questions about these new treatments. Migraine Canada has created a handout to provide basic information. Have a look,...

Dear Colleague, Migraine Canada is inviting patients to participate in a survey to produce a patient review in support of erenumab (Aimovig) for CADTH, (Canadian Agency for Drugs and Technologies in Health). Migraine Canada is committed to provide reviews...

Dear CHS colleagues, Please find a message from the AHS president, Kathleen Digre, summarizing some aspects of CGRP MAB therapy. Exciting prospects ahead (and lots of forms) -- Elizabeth Leroux, MD, FRCPC Clinical Associate Professor, Neurology Headache...

The National Neurology Resident Headache Course was held at the Women's College Hospital in Toronto in October. This year, our guest speaker was Deborah Friedman, from Texas, who gave excellent presentations on Headache and the eye and Pseudotumor Cerebri. For the...

Many neurology residents in Canada do not have access to proper training in headache medicine. In Toronto though, things have been much improved since Dr Christine Lay and Jonathan Gladstone took charge. There is a now a one-month elective available to neurology...

Not enough time is dedicated to headache in GP residency programs. There is a huge need for more guidance on headache medicine for family practitioners. Dr Werner Becker, director of the Calgary Headache Program (CHAMP), and treasurer of our society, has recently...